COMPARATIVE SUSCEPTIBILITIES OF CAMPYLOBACTER-PYLORI TO NORFLOXACIN AND OTHER AGENTS

被引:25
作者
SHUNGU, DL
NALIN, DR
GILMAN, RH
GADEBUSCH, HH
CERAMI, AT
GILL, C
WEISSBERGER, B
机构
[1] MERCK SHARP & DOHME RES LABS,INFECT DIS SERV,RAHWAY,NJ 07065
[2] JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT INT RELAT,BALTIMORE,MD 21205
关键词
D O I
10.1128/AAC.31.6.949
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:949 / 950
页数:2
相关论文
共 10 条
[1]   RELATION OF CAMPYLOBACTER-PYLORIDIS TO GASTRITIS AND PEPTIC-ULCER [J].
BUCK, GE ;
GOURLEY, WK ;
LEE, WK ;
SUBRAMANYAM, K ;
LATIMER, JM ;
DINUZZO, AR .
JOURNAL OF INFECTIOUS DISEASES, 1986, 153 (04) :664-669
[2]   FAMOTIDINE - PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND A PRELIMINARY REVIEW OF ITS THERAPEUTIC USE IN PEPTIC-ULCER DISEASE AND ZOLLINGER-ELLISON SYNDROME [J].
CAMPOLIRICHARDS, DM ;
CLISSOLD, SP .
DRUGS, 1986, 32 (03) :197-221
[3]   THE MINIMUM INHIBITORY AND BACTERICIDAL CONCENTRATIONS OF ANTIBIOTICS AND ANTIULCER AGENTS AGAINST CAMPYLOBACTER-PYLORIDIS [J].
GOODWIN, CS ;
BLAKE, P ;
BLINCOW, E .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 17 (03) :309-314
[4]   NORFLOXACIN - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE [J].
HOLMES, B ;
BROGDEN, RN ;
RICHARDS, DM .
DRUGS, 1985, 30 (06) :482-513
[5]  
KASPER G, 1985, EUR J CLIN MICROBIOL, V3, P444
[6]  
MARSHALL BJ, 1986, LANCET, V1, P965
[7]   PYLORIC CAMPYLOBACTER INFECTION AND GASTRODUODENAL DISEASE [J].
MARSHALL, BJ ;
MCGECHIE, DB ;
ROGERS, PA ;
GLANCY, RJ .
MEDICAL JOURNAL OF AUSTRALIA, 1985, 142 (08) :439-444
[8]  
MARSHALL BJ, 1984, LANCET, V1, P1311
[9]   SUSCEPTIBILITY OF CLINICAL ISOLATES OF CAMPYLOBACTER-PYLORIDIS TO 11 ANTIMICROBIAL AGENTS [J].
MCNULTY, CAM ;
DENT, J ;
WISE, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (06) :837-838
[10]   CHARACTERIZATION OF CAMPYLOBACTER-PYLORIDIS BY CULTURE ENZYMATIC PROFILE, AND PROTEIN-CONTENT [J].
MEGRAUD, F ;
BONNET, F ;
GARNIER, M ;
LAMOULIATTE, H .
JOURNAL OF CLINICAL MICROBIOLOGY, 1985, 22 (06) :1007-1010